Pediatric Leptospirosis
- Author: Patrick W Hickey, MD, FAAP; Chief Editor: Russell W Steele, MD more...
Background
Leptospirosis is a worldwide zoonosis caused by pathogenic species of the genus Leptospira. In 90% of cases, leptospirosis manifests as an acute febrile illness with a biphasic course and an excellent prognosis. Nonspecific signs and symptoms of leptospirosis (eg, fever, headache, nausea, vomiting) are often confused with viral illness.
In 10% of cases, the presentation is more dramatic, and the infection has a mortality rate of 10%. Known as Weil disease or icteric leptospirosis, the classic definition of this form of leptospirosis includes fever, jaundice, renal failure, and hemorrhage. Other organ systems (ie, pulmonary system, cardiac system, CNS) are also frequently involved.
Weil is credited with first describing leptospirosis as a unique disease process in 1886, 30 years before Inada and colleagues identified the causal organism.[1]
The genus Leptospira belongs to the Leptospiraceae family of the order Spirochaetales. The nomenclature system used to organize leptospires has been revised, making review of the literature often confusing. The traditional system divided the genus into 2 species: the pathogenic Leptospira interrogans and the nonpathogenic Leptospira biflexa. These species were divided further into serogroups, serovars, and strains based on shared antigens. L interrogans included more than 250 serovars.
The current classification system is based on DNA homology and recognizes the heterogeneity of the classic leptospires, dividing L interrogans and L biflexa into 12 named species, 4 unnamed species, and 2 additional genera.[2]
- Leptospira interrogans
- Leptospira weilii
- Leptospira santarosai
- Leptospira noguchi
- Leptospira borgpetersenii
- Leptospira kirschner
- Leptospira alexanderi
- Leptospira inadai (pathogenicity unclear)
- Leptospira fainei (pathogenicity unclear)
- Leptospira meyeri (pathogenicity unclear)
- L biflexa (saprophytes)
- Leptospira wolbachi (saprophytes)
- Unnamed Genomospecies 1 (pathogenicity unclear), 3 (saprophytes), 4, and 5 (saprophytes)
- Turneria parva (formerly Leptospira parva, saprophytes)
- Leptonema illini (saprophytes)
Within these species, leptospires are further grouped by serogroups, serovars, and strains on the basis of microscopic agglutination testing (MAT). Serologic grouping may, however, cross DNA based species boundaries. Although certain species (eg, L interrogans) have a classic association with Weil disease, knowledge of the species type does not necessarily help predict disease severity.
Leptospires infect many types of mammals including rats, dogs, cats, cattle, pigs, squirrels, raccoons, mongooses, and bandicoots.[3, 4] Leptospiral species' and serogroups' host animals vary from region to region. Individual animals may carry several serovars.
Leptospirosis in animals is often subclinical. An infected animal may appear healthy even as it sheds leptospires in its urine. Leptospirosis has also been reported in immunized dogs, a finding possibly explained by either partial immunity or vaccines that did not cover the serovars responsible for the infection. Humans are dead-end hosts for the leptospire. Although both nosocomial and congenital leptospirosis have been described, both are rare.[5, 6]
Leptospires are transmitted via infected urine. Leptospires infect humans by invasion across mucosal surfaces or nonintact skin. Infection may occur via direct contact with urine or through contact with contaminated water and soil. In favorable conditions, leptospires can survive in freshwater for as many as 16 days and in soil for as many as 24 days.[7]
Many published case series focus on seasonal outbreaks and leptospirosis acquired occupationally or recreationally. Seasonal outbreaks associated with changes in local water levels have been described: flood conditions increase risk of exposure to the population at large, and drought causes leptospire concentrations to peak in isolated pools.[8, 9] Animal handlers, farmers, and people active in freshwater sports are well-known high-risk groups for leptospirosis.[10, 11]
Pathophysiology
Leptospire invasion across the epithelium is followed by proliferation and widespread dissemination. Every major organ system may be affected, and leptospire antigens can be detected in affected tissues. Leptospire-mediated injury characterizes the initial phase of the disease. A host-immune response marks onset of the second phase of symptoms.
Although direct invasion of tissue may cause some pathologic effects, researchers note that the marked degree of multiorgan tissue injury appears inconsistent with the number of leptospires found on microscopic examination of tissue. Other mediators induced by the leptospire are the suspected causes of the disease's various manifestations. Research has suggested endotoxin, hemolysin, and lipase as possible sources of pathogenicity. However, the true mechanism of host tissue injury remains unclear and likely involves a complex set of interactions.
The most consistent pathologic finding in leptospirosis is vasculitis of capillaries manifested by endothelial edema, necrosis, and lymphocytic infiltration. Capillary vasculitis is found in every affected organ system. The resulting loss of RBCs and fluid through enlarged junctions and fenestrae, which cause secondary tissue injury, probably accounts for many of the clinical findings.
Capillary vasculitis and leakage cause petechiae, intraparenchymal bleeding, and bleeding along serosa and mucosa. Thrombocytopenia sometimes is observed but is not a consistent finding in patients with bleeding. No disseminated intravascular coagulation (DIC) occurs. Prothrombin time (PT) sometimes increases in patients with leptospirosis, but vitamin K administration and concomitant correction of the PT do not alter the course of bleeding.
Direct hepatic injury appears to cause jaundice, although jaundice resulting from hemolysis and biliary obstruction has been suggested. Vascular congestion and disorganization of the liver cell plates are hallmarks of liver tissue injury in patients with leptospirosis. Hemolytic anemia is not associated consistently with jaundice.
Pulmonary findings are caused by alveolar capillary injury, either focal or diffuse. Interstitial and intra-alveolar edema and bleeding occur in areas affected by vasculitis and, in severe cases, may progress to frank hemorrhage. Regions without infiltrate also are free of vasculitis.
Renal findings include tubular necrosis and, later in the disease course, interstitial nephritis. Capillary vasculitis is readily identified. Although the glomeruli are spared, the progression from normal renal function to decreased glomerular filtration rate (GFR) to renal failure requiring dialysis can be rapid.
Cardiac lesions have been identified in postmortem examinations. In a series of 20 fatal cases, epicardial and endocardial petechiae were present in 70% of the patients, myocardial interstitial edema was present in 90%, lymphocyte/plasma cell infiltrate (consistent with myocarditis) was present in 50%, and coronary arteritis was present in 70%.
Hemorrhage, focal necrosis, and inflammatory infiltration have been documented within the adrenal gland. Although these complications do not appear clinically, some researchers speculate that adrenal insufficiency may mediate, in part, the final vascular collapse associated with fatal leptospirosis.
Epidemiology
Frequency
United States
Leptospirosis, as a clinical entity, is underdiagnosed and underreported. The reported annual incidence ranged from 0.02-0.04 cases per 100,000 persons in 1985-1994. In 1994, 38 leptospirosis cases were reported nationwide,[12] and the Council of State and Territorial Epidemiologists recommended removing leptospirosis from the list of notifiable diseases. Hawaii, which reports the highest annual occurrence rate, had 22 of those 38 confirmed cases. Between June 1998 and February 1999, Hawaii reported 405 suspected cases of leptospirosis; 61 of those cases were confirmed.[13] Case numbers widely varied from island to island within the state. Incidence rates ranged from 2.3-40.2 cases per 100,000 persons, with the highest numbers of cases on Kauai and Hawaii. Serologic MAT of healthy blood donors among the military population in Hawaii showed a seroprevalence of 1.4%.[14]
These reported cases starkly contrast with the prevalence rates found under active surveillance.[15] Using active surveillance measures, Hawaiian researchers projected the state's true local incidence at approximately 128 cases per 100,000 persons. Major risk factors identified in Hawaii include the use of water catchment systems, wild pig hunting, and the presence of skin wounds.
Although less dramatic and often unrecognized, people with no obvious risk factor have significantly higher background infection rates than reports often indicate. Approximately 30% of children in urban Detroit[16] and 16% of adults in Baltimore[17] demonstrated serologic evidence of past infection. This pattern has been reproduced elsewhere; rural and suburban seropositivity rates reportedly lag behind urban rates. The Detroit study also showed correlation between degree of rat infestation and seropositivity rates. This finding suggests rats are major, if not the most important, vectors for human leptospirosis in the mainland United States. In Hawaii, the state with the highest reported incidence of leptospirosis, feral pigs are also important vectors.[15]
International
Leptospirosis has been documented worldwide, but formal reporting systems widely vary. Reported incidence rates often are comparable to those in the United States and suffer from the same pitfalls. High-risk areas include the Caribbean islands, Central and South America, Southeast Asia, and the Pacific islands. Frequently, the disease gains public attention when outbreaks occur in association with natural disasters, such as flooding in Nicaragua in 1995 or among foreign travelers, as with extreme athletes competing in tropical rainforests.
Mortality/Morbidity
In 10% of cases, leptospirosis has severe manifestations including renal failure, hepatitis, pulmonary hemorrhage, reaching mortality rates of 10%.
Sex
Leptospirosis is most common among adult males, probably resulting from occupational and recreational exposures. In the converse, the difference in rates may be caused by practitioners who are more likely to look for and, hence, diagnose the disease in patients who have obvious risk factors. When population groups other than adult males are actively surveyed, prevalence rates are higher than those previously reported.
Age
Although most case series and reviews of leptospirosis indicate men as the key risk group, outbreaks have been reported in which more than 40% of patients were younger than 15 years, a reversal of traditional prevalence rates. Potential explanations in such cases include childhood predilections to play with suspected vectors (eg, dogs) or indiscriminate contact with water. Active surveillance measures have detected leptospire antibodies in as many as 30% of children in some urban American populations.
Inada R, Ido Y, Hoki R. The etiology, mode of infection, and specific therapy of Weil's disease (spirochaetosis icterohaemorrhagica). J Exper Med. 1916;23:377-402.
World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control. Available at http://whqlibdoc.who.int/hq/2003/WHO_CDS_CSR_EPH_2002.23.pdf. Accessed September 17, 2008.
Gillespie RW, Ryno J. Epidemiology of leptospirosis. Am J Public Health. Jun 1963;53:950-5. [Medline].
Heisey GB, Nimmanitya S, Karnchanachetanee C, et al. Epidemiology and characterization of leptospirosis at an urban and provincial site in Thailand. Southeast Asian J Trop Med Public Health. Jun 1988;19(2):317-22. [Medline].
Barkin RM, Guckian JC, Glosser JW. Infection by leptospira ballum: a laboratory-associated case. South Med J. Feb 1974;67(2):155 passim. [Medline].
Shaked Y, Shpilberg O, Samra D, Samra Y. Leptospirosis in pregnancy and its effect on the fetus: case report and review. Clin Infect Dis. Aug 1993;17(2):241-3. [Medline].
Smith DJ, Self HR. Observations on the survival of Leptospira australis A in soil and water. J Hyg (Lond). Dec 1955;53(4):436-44. [Medline].
Trevejo RT, Rigau-Perez JG, Ashford DA, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis. Nov 1998;178(5):1457-63. [Medline].
Jackson LA, Kaufmann AF, Adams WG, et al. Outbreak of leptospirosis associated with swimming. Pediatr Infect Dis J. Jan 1993;12(1):48-54. [Medline].
Everard CO, Bennett S, Edwards CN, et al. An investigation of some risk factors for severe leptospirosis on Barbados. - Carrington DG. Feb 1992;95(1):13-22. [Medline].
Katz AR, Manea SJ, Sasaki DM. Leptospirosis on Kauai: investigation of a common source waterborne outbreak. Am J Public Health. Oct 1991;81(10):1310-2. [Medline].
US Department of Health and Human Services. Summary of notifiable diseases, United States 1995. MMWR Morb Mortal Wkly Rep. Oct 25 1996;44(53):1-87. [Medline].
Malani J, Pryor J, Lusangulira K. Leptospirosis in Pohnpei (1986-1995): a case series on the use of dopamine/steroid for Weil's syndrome. Pacific Health Dialog. 1996;3:153-61.
Lettieri C, Moon J, Hickey P, et al. Prevalence of leptospira antibodies in U.S. Army blood bank donors in Hawaii. Mil Med. Sep 2004;169(9):687-90. [Medline].
Sasaki DM, Pang L, Minette HP, et al. Active surveillance and risk factors for leptospirosis in Hawaii. Am J Trop Med Hyg. Jan 1993;48(1):35-43. [Medline].
Demers RY, Thiermann A, Demers P, Frank R. Exposure to Leptospira icterohaemorrhagiae in inner-city and suburban children: a serologic comparison. J Fam Pract. Dec 1983;17(6):1007-11. [Medline].
Childs JE, Schwartz BS, Ksiazek TG, Graham RR, LeDuc JW, Glass GE. Risk factors associated with antibodies to leptospires in inner-city residents of Baltimore: a protective role for cats. Am J Public Health. Apr 1992;82(4):597-9. [Medline].
Hawaii Dept of Health. Communicable Disease Surveillance. Hawaii: Communicable Disease Report; Nov/Dec 1999. 15.
Person DA, Burnett MW. Leptospirosis- Tripler Army Medical Center. Medical Surveillance Monthly Report. 1996;2:7-8. [Full Text].
Person DA. Leptospirosis in the Pacific: Tripler Army Medical Center. Medical Surveillance Monthly Report. 1998;4:12-14. [Full Text].
Musgrave JE, Person DA. Acute renal failure in children due to leptospirosis. Pac Health Dialog. 1996;3:200-1.
Watt G, Padre LP, Tuazon M, Calubaquib C. Skeletal and cardiac muscle involvement in severe, late leptospirosis. J Infect Dis. Jul 1990;162(1):266-9. [Medline].
Arean VM. The pathologic anatomy and pathogenesis of fatal human leptospirosis (Weil's disease). Am J Pathol. Apr 1962;40:393-423. [Medline].
Phimda K, Hoontrakul S, Suttinont C, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother. Sep 2007;51(9):3259-63. [Medline].
Murray CK, Hospenthal DR. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother. Oct 2004;48(10):4002-5. [Medline].
Watt G, Padre LP, Tuazon ML, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet. Feb 27 1988;1(8583):433-5. [Medline].
Costa E, Lopes AA, Sacramento E, et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo. May-Jun 2003;45(3):141-5. [Medline].
Trivedi SV, Chavda RK, Wadia PZ, et al. The role of glucocorticoid pulse therapy in pulmonary involvement in leptospirosis. J Assoc Physicians India. Sep 2001;49:901-3. [Medline].
Shenoy VV, Nagar VS, Chowdhury AA, et al. Pulmonary leptospirosis: an excellent response to bolus methylprednisolone. Postgrad Med J. Sep/2006;82:601-6. [Medline].
Martins MG, Matos KT, da Silva MV, de Abreu MT. Ocular manifestations in the acute phase of leptospirosis. Ocul Immunol Inflamm. Jun 1998;6(2):75-9. [Medline].
Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med. Feb 23 1984;310(8):497-500. [Medline].
Abdulkader RC, Seguro AC, Malheiro PS, et al. Peculiar electrolytic and hormonal abnormalities in acute renal failure due to leptospirosis. Am J Trop Med Hyg. Jan 1996;54(1):1-6. [Medline].
Arean VM. Studies on the pathogenesis of leptospirosis. II. A clinicopathologic evaluation of hepatic and renal function in experimental leptospiral infections. Lab Invest. Apr 1962;11:273-88. [Medline].
Arean VM, Sarasin G, Green JH. The pathogenesis of leptospirosis: toxin production by leptospira icterohaemorrhagiae. Am J Vet Res. May 1964;25:836-43. [Medline].
Barkay S, Garzozi H. Leptospirosis and uveitis. Ann Ophthalmol. Feb 1984;16(2):164-8. [Medline].
Bauer DC, Eames LN, Sleight SD, Ferguson LC. The significance of leptospiral hemolysin in the pathogenesis of Leptospira pomona infections. J Infect Dis. Mar-Apr 1961;108:229-36. [Medline].
Bowsher B, Callahan CW, Person DA, Ruess L. Unilateral leptospiral pneumonia and cold agglutinin disease. Chest. Sep 1999;116(3):830-2. [Medline].
Cargill WH, Beeson PB. The value of spinal fluid examination as a diagnostic procedure in Weil's disease. Ann Intern Med. 1947;27:396-400.
De Brito T, Bohm GM, Yasuda PH. Vascular damage in acute experimental leptospirosis of the guinea-pig. J Pathol. Aug 1979;128(4):177-82. [Medline].
De Brito T, Morais CF, Yasuda PH, et al. Cardiovascular involvement in human and experimental leptospirosis: pathologic findings and immunohistochemical detection of leptospiral antigen. Ann Trop Med Parasitol. Jun 1987;81(3):207-14. [Medline].
Effler PV, Bogard AK, Domen HY, Katz AR, Higa HY, Sasaki DM. Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J Clin Microbiol. Apr 2002;40(4):1464-9. [Medline].
Effler PV, Domen HY, Bragg SL, Aye T, Sasaki DM. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis in Hawaii. J Clin Microbiol. Mar 2000;38(3):1081-4. [Medline].
Emmanouilides CE, Kohn OF, Garibaldi R. Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report. Clin Infect Dis. Jun 1994;18(6):1004-6. [Medline].
Finco DR, Low DG. Endotoxin properties of Leptospira canicola. Am J Vet Res. Nov 1967;28(127):1863-72. [Medline].
Kasarov LB, Addamiano L. Metabolism of the lipoproteins of serum by leptospires: degradation of the triglycerides. J Med Microbiol. May 1969;2(2):165-8. [Medline].
Levett PN, Branch SL, Whittington CU, et al. Two methods for rapid serological diagnosis of acute leptospirosis. Clin Diagn Lab Immunol. Mar 2001;8(2):349-51. [Medline].
Levett PN, Whittington CU. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis. J Clin Microbiol. Jan 1998;36(1):11-4. [Medline].
Marotto PC, Marotto MS, Santos DL, et al. Outcome of leptospirosis in children. Am J Trop Med Hyg. Mar 1997;56(3):307-10. [Medline].
McClain JB, Ballou WR, Harrison SM, Steinweg DL. Doxycycline therapy for leptospirosis. Ann Intern Med. May 1984;100(5):696-8. [Medline].
McCulloch WF, Braun JL, Robinson RG. Leptospiral Meningitis: report of a case and epidemiologic follow up. J Iowa Med Soc. 1962;52:728-31.
Molner JG, Meyer KF, Raskin HA. Leptospiral infections. JAMA. 1948;136:814-19.
Monno S, Mizushima Y. Leptospirosis with acute acalculous cholecystitis and pancreatitis. J Clin Gastroenterol. Jan 1993;16(1):52-4. [Medline].
Munnich D, Lakatos M. Treatment of human leptospira infections with semicillin (ampicillin) or with amoxil (amoxycillin). Chemotherapy. 1976;22(6):372-80. [Medline].
Nicodemo AC, Duarte MI, Alves VA, et al. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am J Trop Med Hyg. Feb 1997;56(2):181-7. [Medline].
O'Brien MM, Vincent JM, Person DA, Cook BA. Leptospirosis and pancreatitis: a report of ten cases. Pediatr Infect Dis J. May 1998;17(5):436-8. [Medline].
Ramos-Morales F, Diaz-Rivera RS, Cintron-Rivera AA, et al. The pathogenesis of leptospiral jaundice. Ann Intern Med. Nov 1959;51:861-78. [Medline].
Ruof HR, Rudin C, Heininger U. Influenza-like symptoms and thrombocytopenia in a teenager. Pediatr Infect Dis J. Jan 2003;22(1):89, 101-2. [Medline].
Shenberg E, Gerichter CB, Lindenbaum I. Leptospirosis in man, Israel, 1970-1979. Am J Epidemiol. Mar 1982;115(3):352-8. [Medline].
Shpilberg O, Shaked Y, Maier MK, et al. Long-term follow-up after leptospirosis. South Med J. Apr 1990;83(4):405-7. [Medline].
Sitprija V. Renal involvement in human leptospirosis. Br Med J. Jun 15 1968;2(606):656-8. [Medline].
Sitprija V, Evans H. The kidney in human leptospirosis. Am J Med. Dec 1970;49(6):780-8. [Medline].
Stavitsky AB. Studies on the pathogenesis of leptospirosis. J Infect Dis. 1945;76:179-192.
Wong ML, Kaplan S, Dunkle LM, et al. Leptospirosis: a childhood disease. J Pediatr. Apr 1977;90(4):532-7. [Medline].

